Geode Capital Management LLC recently announced the acquisition of new stake in Inpixon (NASDAQ:INPX). The institutional investor has increased its shareholding in the Technology company by 2,465.16% to 0.35 million shares with purchase of 0.34 million shares. This fresh investment now brings its stake to 0.20% valued currently at $19737.0. In addition, SSgA Funds Management, Inc. raised its holdings by 39574.0 to 39574.0 shares.
With over 132.34 million Inpixon (INPX) shares trading Friday and a closing price of $0.05 on the day, the dollar volume was approximately $6.62 million. The shares have shown a negative half year performance of -71.34% and its price on 01/12/24 gained nearly 7.81%. Currently, there are 194.30M common shares owned by the public and among those 189.78M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Inpixon are Fidelity Extended Market Index Fu, Vanguard Extended Market Index Fu, and Fidelity Total Market Index Fund. Fidelity Extended Market Index Fu owns 1.03 million shares of the company’s stock, all valued at over $57461.0. Vanguard Extended Market Index Fu bought 0.3 million shares to see its total holdings expand to 0.58 million shares valued at over $32485.0 and representing 0.33% of the shares outstanding. Fidelity Total Market Index Fund now owns shares totaling to 0.00% of the shares outstanding.
Shares of Inpixon (NASDAQ: INPX) opened at $0.0686, up $0.03 from a prior closing price of $0.04. However, the script later moved the day high at 0.0700, up 7.81%. The company’s stock has a 5-day price change of -6.40% and -51.89% over the past three months. INPX shares are trading -14.06% year to date (YTD), with the 12-month market performance down to -97.39% lower. It has a 12-month low price of $0.04 and touched a high of $2.15 over the same period. INPX has an average intraday trading volume of 11.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -17.17%, -26.60%, and -73.33% respectively.
Institutional ownership of Inpixon (NASDAQ: INPX) shares accounts for 0.46% of the company’s 194.30M shares outstanding. Mutual fund holders own -0.41%, while other institutional holders and individual stakeholders account for 0.92% and — respectively.
It has a market capitalization of $9.38M and a beta (3y monthly) value of 0.79. The earnings-per-share (ttm) stands at -$5.84. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.93% over the week and 16.03% over the month.
Analysts forecast that Inpixon (INPX) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for 2019. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was -$7,897,500 a year ago. EPS should shrink at an annualized rate of 20.00% over the next five years, compared to 92.88% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Inpixon (INPX) as a “Hold” at a consensus score of 3.00. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 1 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
